Last reviewed · How we verify

NCT05398107

Building Emotion Awareness and Mental Health (BEAM): Community Partnership With Family Dynamics

Completed NA Last updated 22 March 2023
What this trial tests

NA trial testing Experimental: Building Emotion Awareness and Mental Health (BEAM) in Depression, Anxiety in 80 participants. Completed in 30 December 2022.

Timeline
28 January 2022
Primary endpoint
30 July 2022
30 December 2022

Quick facts

Lead sponsorUniversity of Manitoba
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment80
Start date28 January 2022
Primary completion30 July 2022
Estimated completion30 December 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Manitoba

Who can join

18 and older, any sex, with Depression, Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Throughout the COVID-19 pandemic, postpartum depression and anxiety has increased dramatically. This is problematic as mothers in Manitoba must wait 12-18 months for therapeutic services. Children exposed to maternal mental illness in the first few years of life are at risk of negative lifelong adverse effects. Thus, the investigators of this project created and have tested The Building Emotion Awareness and Mental health (BEAM) program, which is an app-based mental health and parenting program for mothers of young children who are experiencing depression and/or anxiety. BEAM is now ready to be tested in partnership with an established community agency. This partnership will enable counsellors to provide expert-led mental health treatment to supplement and expand upon existing mental health services and will enable an established agency to address widespread unmet family mental health needs through the provision of mobile health (mHealth) content, training, and consultation. A two-arm pilot randomized controlled trial (RCT) with repeated measures will be used to evaluate the BEAM program compared to MoodMission (an evidence-based mHealth program) which will be the standard of care. Outcomes will be assessed to determine the effects of the BEAM program on reducing maternal mental health symptoms among a sample of 80 mothers who self-report moderate-to-severe symptoms of depression and/or anxiety (on the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7, respectively), meet criteria for a current major depressive episode and/or anxiety disorder (as determined on the Mini International Neuropsychiatric Interview) and have a child between the ages of 6 to 18 months old.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The Building Emotional Awareness and Mental health (BEAM) program developed with a community partner for mothers of infants: protocol for a feasibility randomized controlled trial.
    Joyce KM, Rioux C, MacKinnon AL, Katz LY, et al · · 2023 · cited 1× · PMID 36895006 · DOI 10.1186/s40814-023-01260-y
  2. Bridging the Gap: A Secondary Data Analysis of Implementation Outcomes and Symptom Trajectories of an eHealth Mental Health and Parenting Treatment Among Mothers With and Without At-Risk Substance Use.
    Joyce KM, McHardy RJW, Kelly LE, Reynolds K, et al · · 2026 · PMID 41970406 · DOI 10.1177/29768357261438586
  3. The Building Emotional Awareness and Mental health (BEAM) program developed with a community partner for mothers of infants: Protocol for a feasibility randomized controlled trial
    Joyce KM, Rioux C, MacKinnon AL, Katz LY, et al · · 2022 · DOI 10.21203/rs.3.rs-2235864/v1
  4. The Building Emotional Awareness and Mental health (BEAM) program developed with a community partner for mothers of infants: A study protocol for a pilot randomized controlled trial
    Joyce KM, Rioux C, MacKinnon A, Katz L, et al · · 2022 · DOI 10.31234/osf.io/czt8h

Verify or expand the search:

Other recruiting trials for Depression, Anxiety

Currently open trials in the same condition.

Other University of Manitoba trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05398107.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing